Diphtheria and Tetanus Toxoids Adsorbed vaccine contraindications and precautions (Discontinued by the manufacturer in 2023).
-
- Serious allergic or hypersensitivity reaction to a previous shot, or to any diphtheria or tetanus toxoid vaccine;
- Apnea following intramuscular vaccination has been observed in some infants born prematurely. Diphtheria and Tetanus Toxoid Absorbed vaccine product insert warns that the decision to vaccinate an infant born prematurely should take into consideration both the potential risks and possible benefits of vaccination;
- If Guillain-Barré Syndrome (GBS) occurred within six weeks of a previous tetanus toxoid vaccine, the risk of a recurrent case may be increased following vaccination with Diphtheria and Tetanus Toxoid Adsorbed.
Diphtheria and Tetanus Toxoid Adsorbed is FDA approved for use in infants and children between six weeks through six years of age. Diphtheria and Tetanus Toxoid Adsorbed should not be administered to infants younger than six weeks or children older than six years of age.
